Drug Targets

Research discussing potential therapeutic coronavirus targets

Published and Preprint Papers

Title

Altmetric

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.

A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing

The Global Phosphorylation Landscape of SARS-CoV-2 Infection.

Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis.

Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.

A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19.

Targeting potential drivers of COVID-19: Neutrophil extracellular traps.

Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry.

SARS-CoV-2 RBD in vitro evolution follows contagious mutation spread, yet generates an able infection inhibitor